Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 2, 2002, Pages 429-438

  DiBiase, Steven J ^a   Hosseinzadeh, Keya ^a   Gullapalli, Rao P ^a   Jacobs, Stephen C ^a   Naslund, Michael J ^a   Sklar, Geoffrey N ^a   Alexander, Richard B ^a   Yu, Cedric ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Magnetic resonance spectroscopy; Prostate cancer

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; DOSIMETRY; MAGNETIC RESONANCE IMAGING; TUMORS;

MAGNETIC RESONANCE SPECTROSCOPIC IMAGING (MRSI);

ONCOLOGY;

CHOLINE; CITRIC ACID; CREATINE; IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMAGE ANALYSIS; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; TECHNIQUE; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING; TUMOR VOLUME;

AGED; BRACHYTHERAPY; FEASIBILITY STUDIES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 0036471751     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02609-8     Document Type: Article

References (39)

1. Recommendations for permanent prostate brachytherapy postimplant analysis
2. Modern prostate brachytherapy; Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up
3. Palladium-103 brachytherapy for prostate carcinoma
4. A comprehensive review of prostate brachytherapy; Defining an optimal technique
5. Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen
6. Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants
7. Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer
8. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy; A pilot study
9. Magnetic resonance with endorectal coil in the local staging of prostatic carcinoma; Comparison with histologic macrosections in 40 cases
10. 31P magnetic resonance spectroscopic profiles of neoplastic human breast tissues
11. Bioenergetic theory of prostate malignancy
12. Citrate in the diagnosis of prostate cancer
13. Citrate metabolism of the normal, and malignant prostate epithelial cells
14. Citrate alterations in primary and metastatic human prostatic adenocarcinomas; 1H magnetic resonance spectroscopy and biochemical study
15. Phosphorus metabolite characterization of human prostatic adenocarcinoma in a nude mouse model by 31P magnetic resonance spectroscopy, and high pressure liquid chromatography
16. 31P spectroscopy of the human prostate gland in vivo using a transrectal probe
17. Detection of locally recurrent prostate cancer after cryosurgery; Evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy
18. Localizing prostate cancer in the presence of postbiopsy changes on MR images; Role of proton MR spectroscopic imaging
19. 3) spatial resolution
20. The prostate; MR imaging and spectroscopy-Present and future
21. Magnetic resonance spectroscopy in prostate disease; Diagnostic possibilities and future developments
22. Dose escalation with three-dimensional conformal radiation therapy affects outcome in prostate cancer
23. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy
24. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer; Further evidence for a significant dose effect
25. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy
26. A dose response study for I-125 prostate implants
27. What is the optimal dose for I-125 prostate implants? A dose-response analysis of long term urinary symptoms, biochemical control and post-treatment biopsy
28. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate; Analysis of RTOG studies 7506 and 7706
29. Controversies in the radiologic diagnosis of pelvic malignancies
30. [Imaging diagnosis of prostatic cancer]
31. Magnetic resonance imaging of the genitourinary tract
32. [Prostatic carcinoma; Appearance in magnetic resonance imaging]
33. Magnetic resonance imaging in urology
34. Magnetic resonance imaging of the prostate
35. Towards multidimensional radiotherapy (MD-CRT); Biological imaging and biological conformality
36. Prostate cancer; Metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging
37. Postimplantation dosimetric analysis of permanent transperineal prostate implantation; Improved dose distributions with an intraoperative computer-optimized conformal planning technique
38. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging
39. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90. Gy compared to seven field 3-dimensional radiotherapy